Qualigen Therapeutics Inc. logo

Qualigen Therapeutics Inc.

QLGN | NASDAQ
Chart Builder DCF Calculator
$3.21
+$0.17 (+5.59%)
At close: Nov 18, 2025, 04:00 PM ET
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
Net Income
-16.97M -6.36M -12.48M -11.5M -17.9M -20.42M
Depreciation & Amortization
n/a n/a 4.5K 12.17K 338.28K 314.2K
Stock-Based Compensation
268 128.06K 1.1M 4.77M 5.29M 2.81M
Other Working Capital
1.9M -338.44K -491.84K -1.02M 1.68M -2.34M
Other Non-Cash Items
8.47M 687.21K -43.86K -1.12M -4.68M 9.68M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a
Change in Working Capital
1.55M -783.58K 1.11M -642.87K 2.21M -2.12M
Operating Cash Flow
-6.95M -6.33M -10.3M -13.25M -14.73M -9.76M
Capital Expenditures
n/a n/a n/a -319.12K -141.36K -210.19K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-15.88M -1.91M 4.22M -183.76K -6.89K 49.64K
Investing Cash Flow
-15.88M -1.91M 4.22M -183.76K -141.36K -160.56K
Debt Repayment
-920.5K 1.48M -550K 2.9M -138.74K 165.14K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a
Dividend Paid
-2.56M -87.6K n/a n/a n/a n/a
Other Financial Acitivies
2.56M 4.56K n/a -505 -247.45K 33.76M
Financial Cash Flow
40.99M 9.01M -550K 2.91M 8.43M 33.76M
Net Cash Flow
18.16M 772.81K -6.64M -14.37M -6.44M 28K
Free Cash Flow
-6.95M -6.33M -10.3M -13.57M -14.87M -9.97M
Adj. Free Cash Flow
-6.95M -6.46M -11.4M -18.33M -20.17M -12.77M
Maintenance CapEx
n/a n/a n/a -319.12K -22.52K -210.19K
Growth CapEx
n/a n/a n/a n/a -118.84K n/a
Owner Earnings
-6.95M -6.33M -10.3M -13.57M -14.75M -9.97M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.